Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey.

Hébuterne, Xavier; Vavricka, Stephan R; Thorne, Helen C; MacKenzie-Smith, Lara; Laoun, Raphaël; Burisch, Johan

Hébuterne, Xavier; Vavricka, Stephan R; Thorne, Helen C; MacKenzie-Smith, Lara; Laoun, Raphaël; Burisch, Johan.

Afiliación

Hébuterne X; Gastro-entérologie et Nutrition Clinique, CHU de Nice, Université Côte d'Azur, Nice, France.
Vavricka SR; Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland.
Thorne HC; Tillotts Pharma AG, Rheinfelden, Switzerland.
MacKenzie-Smith L; Tillotts Pharma AG, Rheinfelden, Switzerland.
Laoun R; Tillotts Pharma AG, Rheinfelden, Switzerland.
Burisch J; Gastrounit, Medical Division, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.

Inflamm Intest Dis ; 8(1): 41-49, 2023 Jun 01.

Article en En | MEDLINE | ID: mdl-37711959

Palabras clave

Adherence; Compliance; Mesalazine; Oral therapy; Patient preference; Ulcerative colitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Inflamm Intest Dis Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google